This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2012 Jun 7;30(6):475-7.

doi: 10.1038/nbt0612-475.

Anti-IL-17 mAbs herald new options in psoriasis

PMID: 22678368
DOI: 10.1038/nbt0612-475

Anti-IL-17 mAbs herald new options in psoriasis

Ken Garber. Nat Biotechnol. 2012.

. 2012 Jun 7;30(6):475-7.

doi: 10.1038/nbt0612-475.

Author

PMID: 22678368
DOI: 10.1038/nbt0612-475

No abstract available

PubMed Disclaimer

Similar articles

Therapeutic Targeting of IL-17 and IL-23 Cytokines in Immune-Mediated Diseases.
Fragoulis GE, Siebert S, McInnes IB. Fragoulis GE, et al. Annu Rev Med. 2016;67:337-53. doi: 10.1146/annurev-med-051914-021944. Epub 2015 Nov 4. Annu Rev Med. 2016. PMID: 26565676 Review.
Monoclonal antibodies inhibiting IL-12, -23, and -17 for the treatment of psoriasis.
Jeon C, Sekhon S, Yan D, Afifi L, Nakamura M, Bhutani T. Jeon C, et al. Hum Vaccin Immunother. 2017 Oct 3;13(10):2247-2259. doi: 10.1080/21645515.2017.1356498. Hum Vaccin Immunother. 2017. PMID: 28825875 Free PMC article. Review.
IL-17 antibodies gain momentum.
Tse MT. Tse MT. Nat Rev Drug Discov. 2013 Nov;12(11):815-6. doi: 10.1038/nrd4152. Nat Rev Drug Discov. 2013. PMID: 24172318 No abstract available.
Therapeutics: Silencing psoriasis.
Crow JM. Crow JM. Nature. 2012 Dec 20;492(7429):S58-9. doi: 10.1038/492S58a. Nature. 2012. PMID: 23254974 No abstract available.
IL-17 Blockade in Psoriasis.
Burkett PR, Kuchroo VK. Burkett PR, et al. Cell. 2016 Dec 15;167(7):1669. doi: 10.1016/j.cell.2016.11.044. Cell. 2016. PMID: 27984714

See all similar articles

Cited by

The future of uveitis treatment.
Lin P, Suhler EB, Rosenbaum JT. Lin P, et al. Ophthalmology. 2014 Jan;121(1):365-376. doi: 10.1016/j.ophtha.2013.08.029. Epub 2013 Oct 26. Ophthalmology. 2014. PMID: 24169255 Free PMC article. Review.
How can we manage resistance to antiangiogenic drugs?
Luu DC, Chao J. Luu DC, et al. Clin Investig (Lond). 2014;4(6):483-486. doi: 10.4155/cli.14.46. Clin Investig (Lond). 2014. PMID: 25520773 Free PMC article. No abstract available.
Review of immune-related adverse events in prostate cancer patients treated with ipilimumab: MD Anderson experience.
Gao J, He Q, Subudhi S, Aparicio A, Zurita-Saavedra A, Lee DH, Jimenez C, Suarez-Almazor M, Sharma P. Gao J, et al. Oncogene. 2015 Oct;34(43):5411-7. doi: 10.1038/onc.2015.5. Epub 2015 Feb 9. Oncogene. 2015. PMID: 25659583 Free PMC article. Review.
Immunity to infection in IL-17-deficient mice and humans.
Cypowyj S, Picard C, Maródi L, Casanova JL, Puel A. Cypowyj S, et al. Eur J Immunol. 2012 Sep;42(9):2246-54. doi: 10.1002/eji.201242605. Eur J Immunol. 2012. PMID: 22949323 Free PMC article. Review.
Dermal Vγ₄⁺T cells enhance the IMQ-induced psoriasis-like skin inflammatidon in re-challenged mice.
Zhu R, Cai X, Zhou C, Li Y, Zhang X, Li Y, Ran L, Huang K, He W, Wang R. Zhu R, et al. Am J Transl Res. 2017 Dec 15;9(12):5347-5360. eCollection 2017. Am J Transl Res. 2017. PMID: 29312488 Free PMC article.

See all "Cited by" articles

References

1. Science. 2011 Apr 1;332(6025):65-8 - PubMed
1. Nat Biotechnol. 2011 Jul 11;29(7):563-6 - PubMed
1. N Engl J Med. 2012 Mar 29;366(13):1181-9 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information